1. Home
  2. Live Updates
  3. Hemophilia treatment market

Page 5 - Hemophilia Treatment Market News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hemophilia treatment market. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hemophilia Treatment Market Today - Breaking & Trending Today

Patients with Hemophilia A Without Inhibitors Have Low Physical Activity

Presented at ASH 2023, a new study demonstrated physical activity does not increase bleeding for patients with hemophilia A as patients with low physical activity still experienced frequent bleeding.
....

United States , Marisa Elisa Mancusco , American Society Of Hematology , World Federation Of Hemophilia , World Health Organization , Humanitas Research Hospital In Rozzano , Humanitas Research Hospital Marisa Elisa Mancusco , Research Hospital , World Federation , American Society , Physical Activity , Hemophilia A , Haemophilia A ,

FDA, EMA Accept Regulatory Submission for Marstacimab Treatment of Hemophilia A, B

The submissions to both agencies were based upon positive results from the BASIS trial that had been presented at the American Society of Hematology Annual Meeting.
....

United States , James Rusnak , European Medicines Agency , Drug Administration , Pfizer Inc , European Commission , American Society Of Hematology , Biologics License Application , Prescription Drug User Fee Act , Chief Development Officer , Internal Medicine , Infectious Diseases ,

Gene Therapy Success in UK Likely Depends on Overcoming Education, Psychological Support Challenges

Education, psychological support, and implementation guidance are the top unmet needs identified by investigators from the United Kingdom concerning gene therapy use for hemophilia. ....

United Kingdom , Regulatory Agency , European Medicines Agency , European Haemophilia Consortium , European Commission , United Kingdom Haemophilia Centre Doctor Organisation , Haemophilia Society , Orphanet Journal , Biomarin Pharmaceutical , United Kingdom Medicines , World Federation , Hemophilia Shared Decision Making Tool , Orphanetj Rare , Psychological Support ,

Subcutaneous OCTA101 Trial in Severe Hemophilia A Halted Due to Safety Concerns

In a trial assessing subcutaneous OCTA101 in patients with severe hemophilia A, promising results in pharmacokinetics and efficacy were overshadowed by safety concerns. ....

Blood Cells , Design Cells , Clinical Trial ,

Novo Nordisk offers staff free Wegovy

Novo Nordisk, a Denmark-based drugmaker, reimburses its employees who are prescribed its drugs, including its popular weight loss drug Wegovy. Employees must me ....

Novo Nordisk ,